ArticleCancers2025

Soluble PD-L1 and Serum Vascular Endothelial Growth Factor-B May Independently Predict Prognosis in Patients with Advanced Non-Small Cell Lung Cancer Treated with Pembrolizumab.

Eleni Kokkotou et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.